Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for prostate cancer

W J Kirkels1, J B Rietbergen

  • 1Department of Urology, Academic Hospital Dijkzigt, Rotterdam, The Netherlands.

Urological Research
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

Training robotic surgery in urology: experience and opinions of robot urologists.

The international journal of medical robotics + computer assisted surgery : MRCAS·2014
Same author

Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types.

The British journal of surgery·2012
Same author

Cervical lymph node dissection for metastatic testicular cancer.

Annals of surgical oncology·2010
Same author

Total pelvic exenteration for primary and recurrent malignancies.

World journal of surgery·2009
Same journal

Erratum to: Is routine ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy for lower ureteral stones larger than 1 cm?

Urological research·2017
Same journal

2002 30(th) Munich Endourological Symposium 10-11 October 2002.

Urological research·2014
Same journal

Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).

Urological research·2014
Same journal

Biomolecular mechanism of urinary stone formation involving osteopontin.

Urological research·2012
Same journal

Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

Urological research·2012
Same journal

Role of 1 week of antibiotic prophylaxis before percutaneous nephrolithotomy.

Urological research·2012
See all related articles

Prostate cancer screening aims to detect the disease early in at-risk men. However, routine screening is debated due to concerns about overdiagnosis and overtreatment, pending mortality reduction evidence.

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer is a significant health concern in aging male populations.
  • Increasing mortality rates necessitate effective disease management strategies.

Purpose of the Study:

  • To explore the role of early detection through prostate cancer screening.
  • To address the ongoing debate surrounding the implementation of screening programs.

Main Methods:

  • Review of the concept and purpose of disease screening.
  • Analysis of the challenges and controversies in prostate cancer screening.

Main Results:

  • Screening identifies individuals with a higher probability of having prostate cancer for further diagnosis and treatment.

Related Experiment Videos

  • Concerns regarding overdiagnosis, overtreatment, and treatment side effects complicate screening recommendations.

    • Conclusions:

    • Routine prostate cancer screening should be deferred until multicenter prospective randomized studies confirm a reduction in prostate cancer mortality.
    • Further research is essential to establish the net benefit of prostate cancer screening programs.